Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017
dc.contributor.author | Clayton, Aled | |
dc.contributor.author | Buschmann, Dominik | |
dc.contributor.author | Byrd, J. Brian | |
dc.contributor.author | Carter, David R. F. | |
dc.contributor.author | Cheng, Lesley | |
dc.contributor.author | Compton, Carolyn | |
dc.contributor.author | Daaboul, George | |
dc.contributor.author | Devitt, Andrew | |
dc.contributor.author | Falcon‐perez, Juan Manuel | |
dc.contributor.author | Gardiner, Chris | |
dc.contributor.author | Gustafson, Dakota | |
dc.contributor.author | Harrison, Paul | |
dc.contributor.author | Helmbrecht, Clemens | |
dc.contributor.author | Hendrix, An | |
dc.contributor.author | Hill, Andrew | |
dc.contributor.author | Hoffman, Andrew | |
dc.contributor.author | Jones, Jennifer C. | |
dc.contributor.author | Kalluri, Raghu | |
dc.contributor.author | Kang, Ji Yoon | |
dc.contributor.author | Kirchner, Benedikt | |
dc.contributor.author | Lässer, Cecilia | |
dc.contributor.author | Lawson, Charlotte | |
dc.contributor.author | Lenassi, Metka | |
dc.contributor.author | Levin, Carina | |
dc.contributor.author | Llorente, Alicia | |
dc.contributor.author | Martens‐uzunova, Elena S. | |
dc.contributor.author | Möller, Andreas | |
dc.contributor.author | Musante, Luca | |
dc.contributor.author | Ochiya, Takahiro | |
dc.contributor.author | Pink, Ryan C | |
dc.contributor.author | Tahara, Hidetoshi | |
dc.contributor.author | Wauben, Marca H. M. | |
dc.contributor.author | Webber, Jason P. | |
dc.contributor.author | Welsh, Joshua A. | |
dc.contributor.author | Witwer, Kenneth W. | |
dc.contributor.author | Yin, Hang | |
dc.contributor.author | Nieuwland, Rienk | |
dc.date.accessioned | 2020-12-02T14:38:17Z | |
dc.date.available | 2020-12-02T14:38:17Z | |
dc.date.issued | 2018-12 | |
dc.identifier.citation | Clayton, Aled; Buschmann, Dominik; Byrd, J. Brian; Carter, David R. F.; Cheng, Lesley; Compton, Carolyn; Daaboul, George; Devitt, Andrew; Falcon‐perez, Juan Manuel ; Gardiner, Chris; Gustafson, Dakota; Harrison, Paul; Helmbrecht, Clemens; Hendrix, An; Hill, Andrew; Hoffman, Andrew; Jones, Jennifer C.; Kalluri, Raghu; Kang, Ji Yoon; Kirchner, Benedikt; Lässer, Cecilia ; Lawson, Charlotte; Lenassi, Metka; Levin, Carina; Llorente, Alicia; Martens‐uzunova, Elena S. ; Möller, Andreas ; Musante, Luca; Ochiya, Takahiro; Pink, Ryan C; Tahara, Hidetoshi; Wauben, Marca H. M.; Webber, Jason P.; Welsh, Joshua A.; Witwer, Kenneth W.; Yin, Hang; Nieuwland, Rienk (2018). "Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017." Journal of Extracellular Vesicles 7(1): n/a-n/a. | |
dc.identifier.issn | 2001-3078 | |
dc.identifier.issn | 2001-3078 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/163591 | |
dc.description.abstract | This report summarises the presentations and activities of the ISEV Workshop on extracellular vesicle biomarkers held in Birmingham, UK during December 2017. Among the key messages was broad agreement about the importance of biospecimen science. Much greater attention needs to be paid towards the provenance of collected samples. The workshop also highlighted clear gaps in our knowledge about preâ analytical factors that alter extracellular vesicles (EVs). The future utility of certified standards for credentialing of instruments and software, to analyse EV and for tracking the influence of isolation steps on the structure and content of EVs were also discussed. Several example studies were presented, demonstrating the potential utility for EVs in disease diagnosis, prognosis, longitudinal serial testing and stratification of patients. The conclusion of the workshop was that more effort focused on preâ analytical issues and benchmarking of isolation methods is needed to strengthen collaborations and advance more effective biomarkers. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | Taylor & Francis | |
dc.subject.other | extracellular vesicles | |
dc.subject.other | Biomarkers | |
dc.subject.other | exosomes | |
dc.subject.other | cancer | |
dc.subject.other | serum | |
dc.subject.other | plasma | |
dc.subject.other | urine | |
dc.title | Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017 | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Medicine (General) | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163591/1/jev2bf00322.pdf | en_US |
dc.identifier.doi | 10.1080/20013078.2018.1473707 | |
dc.identifier.source | Journal of Extracellular Vesicles | |
dc.identifier.citedreference | Lotvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the international society for extracellular vesicles. J Extracell Vesicles. 2014; 3: 26913. | |
dc.identifier.citedreference | Lacroix R, Judicone C, Poncelet P, et al. Impact of preâ analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost. 2012; 10 ( 3 ): 437 â 446. | |
dc.identifier.citedreference | Mullier F, Bailly N, Chatelain C, et al. Preâ analytical issues in the measurement of circulating microparticles: current recommendations and pending questions. J Thromb Haemost. 2013; 11 ( 4 ): 693 â 696. | |
dc.identifier.citedreference | Baek R, Sondergaard EK, Varming K, et al. The impact of various preanalytical treatments on the phenotype of small extracellular vesicles in blood analyzed by protein microarray. J Immunol Methods. 2016; 438: 11 â 20. | |
dc.identifier.citedreference | Lee MJ, Park DH, Kang JH. Exosomes as the source of biomarkers of metabolic diseases. Ann Pediatr Endocrinol Metab. 2016; 21 ( 3 ): 119 â 125. | |
dc.identifier.citedreference | Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature. 2012; 483 ( 7391 ): 531 â 533. | |
dc.identifier.citedreference | Poste G, Compton CC, Barker AD. The national biomarker development alliance: confronting the poor productivity of biomarker research and development. Expert Rev Mol Diagn. 2015; 15 ( 2 ): 211 â 218. | |
dc.identifier.citedreference | Poste G. Bring on the biomarkers. Nature. 2011; 469 ( 7329 ): 1 â 11. | |
dc.identifier.citedreference | Coumans FAW, Brisson AR, Buzas EI, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017; 120 ( 10 ): 1632 â 1648. | |
dc.identifier.citedreference | Van Es N, Di Nisio M, Cesarman G, et al. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study. Haematologica. 2017; 102 ( 9 ): 1494 â 1501. | |
dc.identifier.citedreference | Berckmans RJ, Sturk A, van Tienen LM, et al. Cellâ derived vesicles exposing coagulant tissue factor in saliva. Blood. 2011; 117 ( 11 ): 3172 â 3180. | |
dc.identifier.citedreference | Yang KS, Im H, Hong S, et al. Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy. Sci Transl Med. 2017; 9: 391. | |
dc.identifier.citedreference | Hu J, Sheng Y, Kwak KJ, et al. A signalâ amplifiable biochip quantifies extracellular vesicleâ associated RNAs for early cancer detection. Nat Commun. 2017; 8 ( 1 ): 1683. | |
dc.identifier.citedreference | Melo SA, Luecke LB, Kahlert C, et al. Glypicanâ 1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015; 523 ( 7559 ): 177 â 182. | |
dc.identifier.citedreference | Fernando MR, Jiang C, Krzyzanowski GD, et al. New evidence that a large proportion of human blood plasma cellâ free DNA is localized in exosomes. PLoS One. 2017; 12 ( 8 ): e0183915. | |
dc.identifier.citedreference | Van Deun J, Mestdagh P, Agostinis P, et al. EVâ TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017; 14 ( 3 ): 228 â 232. | |
dc.identifier.citedreference | Witwer KW, Buzas EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013; 2 ( 1 ): 20360. | |
dc.identifier.citedreference | Shet AS. Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag. 2008; 4 ( 4 ): 769 â 774. | |
dc.identifier.citedreference | McDonald JS, Milosevic D, Reddi HV, et al. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011; 57 ( 6 ): 833 â 840. | |
dc.identifier.citedreference | Shin KS, Ji JH, Hwang KS, et al. Sensitivity enhancement of Beadâ based Electrochemical Impedance Spectroscopy (BEIS) biosensor by electric fieldâ focusing in microwells. Biosens Bioelectron. 2016; 85: 16 â 24. | |
dc.identifier.citedreference | Lobb RJ, Hastie ML, Norris EL, et al. Oncogenic transformation of lung cells results in distinct exosome protein profile similar to the cell of origin. Proteomics. 2017; 17: 23 â 24. | |
dc.identifier.citedreference | Zhu S, Ma L, Wang S, et al. Lightâ scattering detection below the level of single fluorescent molecules for highâ resolution characterization of functional nanoparticles. ACS Nano. 2014; 8 ( 10 ): 10998 â 11006. | |
dc.identifier.citedreference | Groot Kormelink T, Arkesteijn GJ, Nauwelaers FA, et al. Prerequisites for the analysis and sorting of extracellular vesicle subpopulations by highâ resolution flow cytometry. Cytometry A. 2016; 89 ( 2 ): 135 â 147. | |
dc.identifier.citedreference | Ferdin J, Goricar K, Dolzan V, et al. Viral protein Nef is detected in plasma of half of HIVâ infected adults with undetectable plasma HIV RNA. PLoS One. 2018; 13 ( 1 ): e0191613. | |
dc.identifier.citedreference | Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013; 382 ( 9903 ): 1525 â 1533. | |
dc.identifier.citedreference | Royo F, Palomo L, Mleczko J, et al. Metabolically active extracellular vesicles released from hepatocytes under drugâ induced liverâ damaging conditions modify serum metabolome and might affect different pathophysiological processes. Eur J Pharm Sci. 2017; 98: 51 â 57. | |
dc.identifier.citedreference | Royo F, Moreno L, Mleczko J, et al. Hepatocyteâ secreted extracellular vesicles modify blood metabolome and endothelial function by an arginaseâ dependent mechanism. Sci Rep. 2017; 7: 42798. | |
dc.identifier.citedreference | Yoshioka Y, Kosaka N, Konishi Y, et al. Ultraâ sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun. 2014; 5: 3591. | |
dc.identifier.citedreference | Cheng L, Sun X, Scicluna BJ, et al. Characterization and deep sequencing analysis of exosomal and nonâ exosomal miRNA in human urine. Kidney Int. 2014; 86 ( 2 ): 433 â 444. | |
dc.identifier.citedreference | Cheng L, Sharples RA, Scicluna BJ, et al. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cellâ free blood. J Extracell Vesicles. 2014; 3 ( 1 ): 23743. | |
dc.identifier.citedreference | Karimi N, Cvjetkovic A, Jang SC, et al. Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins. Cell Mol Life Sci. 2018. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.